Dosage of hemoglobin A1c by isoelectrofocusing

Area of Science:

• Clinical Chemistry
• Analytical Biochemistry
• Diabetology

Background:

• Hemoglobin A1c (HbA1c) is a crucial biomarker for monitoring long-term glycemic control in diabetes.
• Accurate and routine measurement of HbA1c is essential for effective diabetes management.
• Existing methods may have limitations in routine application or precision.

Purpose of the Study:

• To propose and evaluate a new routine method for Hemoglobin A1c (HbA1c) measurement.
• To assess the performance of thin-layer isoelectrofocusing for HbA1c analysis.
• To characterize HbA1c level distributions in normal adults and treated diabetic patients.

Main Methods:

• Development of a novel routine dosage method for HbA1c analysis.
• Application of thin-layer isoelectrofocusing (tIEF) technique.
• Analysis of HbA1c levels in a cohort of normal adults and treated diabetic patients.

Main Results:

• The mean HbA1c level in normal adults was determined to be 4.66% (SD = 1.05).
• HbA1c distribution in treated diabetic patients was found to be non-Gaussian.
• Extreme HbA1c values ranged from 3% to 13%, with a peak frequency at 5.5% in diabetic patients.

Conclusions:

• Thin-layer isoelectrofocusing offers a viable new method for routine HbA1c determination.
• The study provides reference ranges and distribution characteristics for HbA1c in specific populations.
• This method may enhance the routine monitoring of glycemic control.